CAS 102767-28-2
:Levetiracetam
Descripción:
Levetiracetam es un fármaco antiepiléptico utilizado principalmente para tratar la epilepsia y las convulsiones. Se clasifica como un derivado de pirrolidina y es conocido por su mecanismo de acción único, que implica la unión a la proteína de vesícula sináptica 2A (SV2A), modulando así la liberación de neurotransmisores. Levetiracetam se caracteriza por su alta solubilidad en agua y moderada lipofilia, lo que facilita su absorción y distribución en el cuerpo. El compuesto tiene una fórmula molecular de C8H14N2O2 y un peso molecular relativamente bajo. Se administra típicamente en forma de tabletas, solución oral o inyección intravenosa, lo que permite opciones de dosificación flexibles. Levetiracetam generalmente es bien tolerado, con un perfil de efectos secundarios que puede incluir mareos, fatiga y cambios de comportamiento. Es importante destacar que no requiere monitoreo rutinario de los niveles en sangre, lo que lo convierte en una opción conveniente para muchos pacientes. Su eficacia en el control de convulsiones de inicio parcial y sus favorables propiedades farmacocinéticas contribuyen a su uso generalizado en la práctica clínica.
Fórmula:C8H14N2O2
InChI:InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
Clave InChI:InChIKey=HPHUVLMMVZITSG-LURJTMIESA-N
SMILES:[C@@H](C(N)=O)(CC)N1C(=O)CCC1
Sinónimos:- (2S)-2-(2-oxopyrrolidin-1-yl)butanamide
- (S)-1-pyrrolidineacetamid
- 1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (S)-
- Etiracetamum [INN-Latin]
- (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
- LEVITIRACETAM
- 1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (αS)-
- Keppra
- (s)-2-(2-oxopyrrolidin-1-yl)butanamide
- alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
- 1-Pyrrolidineacetamide
- UCB-L 059
- Levetiracetamum [INN-Latin]
- UCB-6474
- UCB-L 059
- alpha-ethyl-2-oxo-
- Levetiracetam
- (αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
- UCB 6474
- Name:(S)-2-(2-Oxopyrrolidin-1-yl)butanamide (Levetiracetam)
- (2R)-2-(2-oxopyrrolidin-1-yl)butanamide
- Levetiracetame
- Levetiracetam [INN]
- Ver más sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 23 productos.
Levetiracetam
CAS:LevetiracetamFórmula:C8H14N2O2Pureza:100.0%Forma y color:WhitePeso molecular:170.10553Levetiracetam impurity standard
CAS:Levetiracetam impurity standardForma y color:White. To. Off-WhiteLEVETIRACETAM CRS
CAS:LEVETIRACETAM CRSFórmula:C8H14N2O2Forma y color:White. Powder.Peso molecular:170.209(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
CAS:Fórmula:C8H14N2O2Pureza:98%Forma y color:SolidPeso molecular:170.2090Levetiracetam
CAS:Levetiracetam (SIB-S1) is a relatively unique anticonvulsant that is typically used in combination with other antiepileptic medications for partial onsetFórmula:C8H14N2O2Pureza:99.67% - 99.86%Forma y color:White Crystalline PowderPeso molecular:170.21Levetiracetam
CAS:Fórmula:C8H14N2O2Pureza:≥ 98.0% (anhydrous basis)Forma y color:White or almost white powderPeso molecular:170.21Levetiracetam-d6 (2,3,3,4,4,4-butyramide-d6) [2(S)-(2-Oxopyrrolidin-1-yl)butyramide]
CAS:Pureza:97 atom % DPeso molecular:176.25Levetiracetam
CAS:Fórmula:C8H14N2O2Pureza:>98.0%(HPLC)(N)Forma y color:White to Almost white powder to crystalPeso molecular:170.21Levetiracetam
CAS:<p>Applications The (S)-enantiomer of Etiracetam (E932970) and the ethyl analog of Piracetam (P500800). Used as an anticonvulsant. Neuroprotective & Neuroresearch Product.<br>References Gower, A.J., et al.: Eur. J. Pharmacol., 222, 193 (1992); Kasteleijn-Noist Trenite, D.G.A., et al.: Epilepsy Res., 25, 225 (1996); Patsalos, P.N., et al.: Pharmacol. Ther., 85, 77 (2000)<br></p>Fórmula:C8H14N2O2Forma y color:NeatPeso molecular:170.21Levetiracetam
CAS:Producto controlado<p>Binds vesicle protein SV2A to alter exocytosis; anti-epileptic</p>Fórmula:C8H14N2O2Pureza:Min. 97.5 Area-%Forma y color:White Off-White PowderPeso molecular:170.21 g/molLevetiracetam - Bio-X ™
CAS:Producto controlado<p>Levetiracetam is a modulates the activity of the synaptic vesicle protein 2A (SV2A) in the brain and is used to treat epilepsy.It is not clear exactly how Levetiracetam affects the activity of SV2A and if this is through inhibiting the release of neurotransmitters. However, it is thought to work by binding to a specific site on SV2A, which interferes with its normal function and ultimately leads to changes in exocytosis. One of the postulated mechanisms of action is that this modulates glutamate release. Levetiracetam is used to treat certain types of seizures in people with epilepsy.<br>Levetiracetam is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.</p>Fórmula:C8H14N2O2Pureza:Min. 95%Forma y color:PowderPeso molecular:170.21 g/mol(S)-2-(2-Oxopyrrolidin-1-yl)butanamide
CAS:Fórmula:C8H14N2O2Pureza:95.0%Forma y color:Solid, White powderPeso molecular:170.212
![Levetiracetam-d6 (2,3,3,4,4,4-butyramide-d6) [2(S)-(2-Oxopyrrolidin-1-yl)butyramide]](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3U%2Fthumb%2FD7571.jpg&w=3840&q=75)
